EP2097410A4 - Dérivés d'hétéroaryl-pyrazole utilisés en tant qu'antagonistes du récepteur cb1 des cannabinoïdes - Google Patents

Dérivés d'hétéroaryl-pyrazole utilisés en tant qu'antagonistes du récepteur cb1 des cannabinoïdes

Info

Publication number
EP2097410A4
EP2097410A4 EP07833072A EP07833072A EP2097410A4 EP 2097410 A4 EP2097410 A4 EP 2097410A4 EP 07833072 A EP07833072 A EP 07833072A EP 07833072 A EP07833072 A EP 07833072A EP 2097410 A4 EP2097410 A4 EP 2097410A4
Authority
EP
European Patent Office
Prior art keywords
cannabinoid
heteroaryl
receptor antagonists
pyrazole derivatives
pyrazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07833072A
Other languages
German (de)
English (en)
Other versions
EP2097410A1 (fr
Inventor
Jinhwa Lee
Jeong Min Kim
Chong-Hwan Jonathan Chang
Suk Ho Lee
Hee Jeong Seo
Suk Youn Kang
Kwang-Seop Song
Jong Yup Kim
Min Ju Kim
Sung-Han Lee
Kwang-Woo Ahn
Myung Eun Jung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GC Biopharma Corp
Original Assignee
Green Cross Corp Korea
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/541,269 external-priority patent/US20080081815A1/en
Application filed by Green Cross Corp Korea filed Critical Green Cross Corp Korea
Publication of EP2097410A1 publication Critical patent/EP2097410A1/fr
Publication of EP2097410A4 publication Critical patent/EP2097410A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
EP07833072A 2006-09-29 2007-09-28 Dérivés d'hétéroaryl-pyrazole utilisés en tant qu'antagonistes du récepteur cb1 des cannabinoïdes Withdrawn EP2097410A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/541,269 US20080081815A1 (en) 2006-09-29 2006-09-29 Heteroaryl-pyrazole derivatives as cannabinoid CB1 receptor antagonists
KR20060132606 2006-12-22
PCT/KR2007/004754 WO2008039023A1 (fr) 2006-09-29 2007-09-28 Dérivés d'hétéroaryl-pyrazole utilisés en tant qu'antagonistes du récepteur cb1 des cannabinoïdes

Publications (2)

Publication Number Publication Date
EP2097410A1 EP2097410A1 (fr) 2009-09-09
EP2097410A4 true EP2097410A4 (fr) 2009-11-25

Family

ID=39234790

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07833072A Withdrawn EP2097410A4 (fr) 2006-09-29 2007-09-28 Dérivés d'hétéroaryl-pyrazole utilisés en tant qu'antagonistes du récepteur cb1 des cannabinoïdes

Country Status (5)

Country Link
EP (1) EP2097410A4 (fr)
JP (1) JP5269795B2 (fr)
KR (1) KR101100028B1 (fr)
CN (1) CN101528740B (fr)
WO (1) WO2008039023A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2025674A1 (fr) 2007-08-15 2009-02-18 sanofi-aventis Tetrahydronaphthaline substituée, son procédé de fabrication et son utilisation en tant que médicament
US8426448B2 (en) * 2008-04-22 2013-04-23 Eli Lilly And Company 1,5-diphenyl-pyrrolidin-2-one compounds as CB-1 ligands
SI2280961T1 (sl) * 2008-04-22 2012-11-30 Lilly Co Eli Spojine difenil pirolidin ona kot ligandi cb
US8916594B2 (en) 2011-04-27 2014-12-23 Shionogi & Co., Ltd. 5-membered ring heteroaromatic derivatives having NPY Y5 receptor antagonistic activity
WO2013005168A2 (fr) * 2011-07-05 2013-01-10 Lupin Limited Modulateurs des récepteurs de cannabinoïdes
JP6543610B2 (ja) 2013-03-14 2019-07-10 ハンター ダグラス インコーポレイテッド 建築物開口部のカバーアセンブリを制御する方法および装置
WO2015162452A1 (fr) * 2014-04-23 2015-10-29 Piramal Enterprises Limited Composés pyrazole substitués comme antagonistes du récepteur cb1 et leurs utilisations
CN108586436A (zh) * 2018-07-06 2018-09-28 南京大学 一类含吲哚骨架的双酰肼类衍生物及其制备方法和应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002100826A2 (fr) * 2001-06-08 2002-12-19 Cytovia, Inc. 3-aryl-5-aryl-[1,2,4]-oxadiazoles et leurs analogues, activateurs des caspases et inducteurs de l'apoptose, et leurs utilisations
US20040077650A1 (en) * 2002-10-18 2004-04-22 Pfizer Inc. Cannabinoid receptor ligands and uses thereof
WO2005018645A1 (fr) * 2003-08-21 2005-03-03 Pfizer Products Inc. Composition pharmaceutique pour la prevention et le traitement de l'accoutumance chez un mammifere

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146721A (en) * 1969-09-12 1979-03-27 Byk Gulden Lomberg Chemische Fabrik Gmbh Pyrazol-4-acetic acid compounds
DE2906252A1 (de) * 1979-02-19 1980-08-28 Merck Patent Gmbh Pyrazolderivate, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung
PH27357A (en) * 1989-09-22 1993-06-21 Fujisawa Pharmaceutical Co Pyrazole derivatives and pharmaceutical compositions comprising the same
FR2714057B1 (fr) 1993-12-17 1996-03-08 Sanofi Elf Nouveaux dérivés du 3-pyrazolecarboxamide, procédé pour leur préparation et compositions pharmaceutiques les contenant.
TW583000B (en) * 2000-06-29 2004-04-11 Shionogi & Co X-type sPLA2 inhibitor as a cancer therapeutical agent
WO2005032550A2 (fr) 2002-12-18 2005-04-14 Smithkline Beecham Corporation Inhibiteurs de la peptide deformylase
US7605171B2 (en) 2003-12-17 2009-10-20 Merck & Co., Inc. (3,4-disubstituted)propanoic carboxylates as S1P (Edg) receptor agonists
US20080255216A1 (en) * 2004-03-29 2008-10-16 Aster Susan D Diaryltriazoles as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase-1
FR2882365B1 (fr) * 2005-02-21 2007-09-07 Sanofi Aventis Sa Derives de 2-(1,5-diphenyl-1h-pyrazol-3-yl)-1,3,4-oxadiazole leur preparation et leur application en therapeutique

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002100826A2 (fr) * 2001-06-08 2002-12-19 Cytovia, Inc. 3-aryl-5-aryl-[1,2,4]-oxadiazoles et leurs analogues, activateurs des caspases et inducteurs de l'apoptose, et leurs utilisations
US20040077650A1 (en) * 2002-10-18 2004-04-22 Pfizer Inc. Cannabinoid receptor ligands and uses thereof
WO2005018645A1 (fr) * 2003-08-21 2005-03-03 Pfizer Products Inc. Composition pharmaceutique pour la prevention et le traitement de l'accoutumance chez un mammifere

Non-Patent Citations (23)

* Cited by examiner, † Cited by third party
Title
BULLETIN DE LA SOCIETE CHIMIQUE DE FRANCE , (3), 917-24 CODEN: BSCFAS; ISSN: 0037-8968, 1971 *
CHEMISCHE BERICHTE , 90, 2401-4 CODEN: CHBEAM; ISSN: 0009-2940, 1957 *
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; ARRIETA, ANA ET AL: "Efficient tautomerization hydrazone-azomethine imine under microwave irradiation. Synthesis of [4,3'] and [5,3']bipyrazoles", XP002550426, retrieved from STN Database accession no. 1998:678997 *
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; BERGEON, MARIE T. ET AL: "Sulfurated organic compounds. VIII. Reaction of phenylhydrazine with 3-aryl-1,2-dithiolylium bisulfates and 3,5-diaryl-1,2-dithiolylium perchlorates. 3-Aryl-1-phenylpyrazoles, 5-aryl-1-phenylpyrazoles, and 3,5-diaryl-1-phenylpyrazoles", XP002550424, retrieved from STN Database accession no. 1971:420283 *
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; CARRILLO, J. R. ET AL: "A complete model for the prediction of 1H- and 13C-NMR chemical shifts and torsional angles in phenyl-substituted pyrazoles", XP002550430, retrieved from STN Database accession no. 2001:321317 *
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; FINAR, I. L. ET AL: "Preparation of some pyrazole derivatives", XP002550431, retrieved from STN Database accession no. 1959:94763 *
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; FINAR, I. L.: "Preparation and properties of some bipyrazolyls", XP002550425, retrieved from STN Database accession no. 1956:12288 *
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; MASLIVETS, A. N. ET AL: "Five-membered 2,3-dioxo heterocycles. XI. Synthesis and chemical transformations of .beta.-aroylhydrazides of aroylpyruvic acids", XP002550421, retrieved from STN Database accession no. 1990:55776 *
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; MILLER, SIDNEY I. ET AL: "Mass spectra of 1,2,3-triazoles", XP002550429, retrieved from STN Database accession no. 1979:473771 *
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; PFLEGER, ROBERT ET AL: ".alpha.-Acylaminoacrylic acid. VII. The action of hypobromite on .alpha.-acetamidocinnamic acid", XP002550428, retrieved from STN Database accession no. 1958:113664 *
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; SHIMANSKAYA, N. P. ET AL: "Polarographic study of derivatives of .DELTA.2-pyrazoline", XP002550422, retrieved from STN Database accession no. 1968:512873 *
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; SHIRONINA, T. M. ET AL: "1,3,4,6-Tetracarbonyl compounds: IV. Reaction of 3,4-dihydroxy-2,4-hexadiene-1,6-diones with hydrazine and arylhydrazines", XP002550427, retrieved from STN Database accession no. 2002:136610 *
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; SHKUMAT, A. P.: "Search for new luminophores with predetermined physicochemical and chemical properties. I. 1,3,5-Triarylpyrazoles", XP002550423, retrieved from STN Database accession no. 2000:55923 *
JOURNAL OF THE CHEMICAL SOCIETY 1205-8 CODEN: JCSOA9; ISSN: 0368-1769, 1955 *
JOURNAL OF THE CHEMICAL SOCIETY 1819-23 CODEN: JCSOA9; ISSN: 0368-1769, 1959 *
JOURNAL OF THE CHEMICAL SOCIETY, PERKIN TRANSACTIONS 1: ORGANIC AND BIO-ORGANIC CHEMISTRY (1972-1999) , (1), 15-19 CODEN: JCPRB4; ISSN: 0300-922X, 1979 *
RUSSIAN JOURNAL OF ORGANIC CHEMISTRY (TRANSLATION OF ZHURNAL ORGANICHESKOI KHIMII) , 37(10), 1486-1494 CODEN: RJOCEQ; ISSN: 1070-4280, 2001 *
See also references of WO2008039023A1 *
TETRAHEDRON , 54(43), 13167-13180 CODEN: TETRAB; ISSN: 0040-4020, 1998 *
TETRAHEDRON , 57(19), 4179-4187 CODEN: TETRAB; ISSN: 0040-4020, 2001 *
VISNIK KHARKIVS'KOGO UNIVERSITETU , (2(CHEM.)), 121-125 CODEN: VKSGA3; ISSN: 0453-8048, 1998 *
ZHURNAL OBSHCHEI KHIMII , 38(8), 1676-9 CODEN: ZOKHA4; ISSN: 0044-460X, 1968 *
ZHURNAL ORGANICHESKOI KHIMII , 25(5), 1039-45 CODEN: ZORKAE; ISSN: 0514-7492, 1989 *

Also Published As

Publication number Publication date
JP2010504961A (ja) 2010-02-18
JP5269795B2 (ja) 2013-08-21
WO2008039023A1 (fr) 2008-04-03
CN101528740A (zh) 2009-09-09
CN101528740B (zh) 2012-09-19
EP2097410A1 (fr) 2009-09-09
KR20090061076A (ko) 2009-06-15
KR101100028B1 (ko) 2011-12-29

Similar Documents

Publication Publication Date Title
HRP20151108T1 (en) Nogo receptor antagonists
EP2058304A4 (fr) Antagoniste du récepteur p2x4
SI2094690T1 (sl) Derivati 2-aza-biciklo(3.1.0)heksana kot antagonisti receptorja za oreksin
IL195071A0 (en) Cannabinoid receptor antagonists/inverse agonists
ZA200800320B (en) Indol-3-carbonyl-spiro-piperidine derivatives as Via receptor antagonists
ZA200909163B (en) Imidazole derivatives as ccr2 receptor antagonists
EP2184278A4 (fr) Antagoniste de récepteur p2x4
IL198990A0 (en) Cb1 receptor modulators
IL196587A0 (en) 2-phenyl-indoles as prostaglandin d2 receptor antagonists
ZA201000395B (en) Substituted piperazines as cb1 antagonists
EP2222165A4 (fr) Nouveaux composés en tant que ligands de récepteur de cannabinoïde et leurs utilisations
PL2069310T3 (pl) Pochodne sulfonylopirazolino-1-karboksyamidyny jako antagoniści 5-HT6
IL194393A0 (en) Benzimidazole 5-sulfonamide derivatives as cannabinoid 1 (cb1) receptor ligands
EP2097410A4 (fr) Dérivés d'hétéroaryl-pyrazole utilisés en tant qu'antagonistes du récepteur cb1 des cannabinoïdes
IL198542A0 (en) 2-aminoquinolines as 5-ht(5a)receptor antagonists
IL194902A0 (en) Sulphur containing pyrazole derivatives as selective cannabinoid cb1 receptor antagonists
SI2099784T1 (sl) 1,5-difenil-3-piridinilamino-1,5-dihidrorirolidin-2-oni kot modulatorji receptorja cb1
ZA200801519B (en) (Indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid CB1 receptor
GB0616467D0 (en) Network tunnelling
ZA200903499B (en) Indoles which act as via receptor antagonists
ZA200802339B (en) Indol-3-yl-carbonyl-azaspiro derivatives as vasopressin receptor antagonists
GB0622569D0 (en) Cannabinoid receptor modulators
ZA200706351B (en) 1H-imidazole derivatives as cannabinoid CB2 receptor modulators
IL188924A0 (en) Imidazopyridine derivatives as cannabinoid receptor ligands
GB201000798D0 (en) Poly-TLR antagonists

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20090330

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 3/04 20060101ALI20091015BHEP

Ipc: A61K 31/4155 20060101ALI20091015BHEP

Ipc: A61K 31/415 20060101ALI20091015BHEP

Ipc: A61P 29/00 20060101ALI20091015BHEP

Ipc: C07D 413/04 20060101ALI20091015BHEP

Ipc: C07D 419/04 20060101AFI20080428BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20091023

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20100720

RIC1 Information provided on ipc code assigned before grant

Ipc: C07D 401/14 20060101ALI20140909BHEP

Ipc: C07D 413/14 20060101ALI20140909BHEP

Ipc: C07D 403/04 20060101ALI20140909BHEP

Ipc: C07D 419/04 20060101AFI20140909BHEP

Ipc: A61K 31/4155 20060101ALI20140909BHEP

Ipc: A61K 31/415 20060101ALI20140909BHEP

Ipc: C07D 417/14 20060101ALI20140909BHEP

Ipc: C07D 403/14 20060101ALI20140909BHEP

Ipc: A61P 29/00 20060101ALI20140909BHEP

Ipc: C07D 409/14 20060101ALI20140909BHEP

Ipc: C07D 417/04 20060101ALI20140909BHEP

Ipc: C07D 405/14 20060101ALI20140909BHEP

Ipc: A61P 3/04 20060101ALI20140909BHEP

Ipc: C07D 413/04 20060101ALI20140909BHEP

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20141021

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20150303